PurpleWin Promotes BioLife’s Virus-Reduced hPL to Help Cell Therapy Developers Meet Regulatory Deman
Exhibitor: PURPLE WIN INTERATIONAL LIMITED.
Date: 2025-06-12
Booth No.: L124
On May 2025, Taiwan’s Ministry of Health and Welfare (MOHW) announced a significant regulatory update for cell therapy. Starting in 2028, all cell therapy applications—including new submissions, amendments, and extensions—must include documented proof of reagent quality along with viral inactivation or clearance validation data. Applications failing to meet these criteria will not be approved. The announcement clearly states that any reagent derived from human or animal sources must be accompanied by risk assessments for potential pathogens and evidence of effective viral inactivation or control measures.
Industry Solution: BioLife’s Virus-Reduced hPL Products – nLiven and TLiven
In response to this regulatory shift, PurpleWin Industrial Co., Ltd. strongly recommends BioLife's virus-reduced human platelet lysate (hPL) products, nLiven and TLiven, developed in the United States. These products utilize proprietary E-beam (electron beam) irradiation technology, offering highly effective pathogen inactivation with deep penetration and low-temperature processing, ensuring protein stability and functionality.
nLiven and TLiven come with comprehensive supporting documentation, including an active Drug Master File (DMF) with the FDA and PMDA applicability documentation in Japan. These products are suitable for clinical use in Taiwan, the U.S., EU, and other regulated markets. With full traceability, quality certification, and virus inactivation performance data, BioLife has become the preferred partner for cell therapy developers navigating evolving compliance requirements.
For more information or technical support, please contact PurpleWin Industrial at +886-2-7720-1566.
More Exhibitor's Press Release
- Honya Medical Strengthens Local Presence and Expands Toward Global Clinical Excellence HONYA MEDICAL CO., LTD. / 2025-07-30
- Honya’s MiSaver: A New Frontier in Treating Heart Damage After Heart Attacks HONYA MEDICAL CO., LTD. / 2025-07-30
- Link-Best debuted at BIO Asia Exhibition. Products attracted attention and Ignited Spark. LINK-BEST BIOSCIENCE CO., LTD. / 2025-07-30
- GoldenBiotech-Advancing First-line treatment of Meta. PanCa GOLDEN BIOTECHNOLOGY CORP. / 2025-07-27
- GlobalBio: 國鼎生技-開發Antroquinonol 造福抗癌研究治療 GOLDEN BIOTECHNOLOGY CORP. / 2025-07-27
- GoldenBiotech Seminar:Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 GOLDEN BIOTECHNOLOGY CORP. / 2025-07-27
- AAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Technology Platform TFBS BIOSCIENCE, INC. / 2025-07-25
- Visit Us at BIO Asia–Taiwan 2025! July 24 – July 27 GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-25
- GBC CellBio™ a2000 has been recognized with a 2025 Edison Award. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- GBC AI Biotech Building Officially Commissioned. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- Your Invitation to Innovation – Booth M412 Forum MAJOR SCIENCE CO.,LTD / 2025-07-24
- Ecotek Engineering Corp.: Your Integrated Partner for Biopharma Facility and Process Equipment Solut MAJOR SCIENCE CO.,LTD / 2025-07-24
- About major science - Create life sciences research instruments through quality and innovation MAJOR SCIENCE CO.,LTD / 2025-07-24
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-07-24
- MarkerX Unveils MyeloTrak™ at BIO Asia, Redefining Multiple Myeloma Management with Non-invasive, Pr MARKER X CO., LTD. / 2025-07-23
- CancerFree Biotech Selected for OIST Startup Accelerator Program CANCERFREE BIOTECH LTD. / 2025-07-23
- AI Sparks a New Wave in Cancer Research: How a Taiwanese Startup Is Breaking Lab Bottlenecks and Ad CANCERFREE BIOTECH LTD. / 2025-07-23
- Transin Biomedical showcases the innovative strength of smart medical devices TRANSIN BIOMEDICAL CO., LTD. / 2025-07-23
- TaiMed Biologics Hosts Interactive Activities at BIO Asia 2025 to Promote HIV Awareness TAIMED BIOLOGICS INC. / 2025-07-22
- A Pioneer for Over Two Decades, Cell-Bio Biotechnology to Showcase Comprehensive Solutions at BioAsi CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-07-22